Adaptogen
A marketing and herbal-medicine term for substances claimed to help the body respond to stress. It is not a precise regulatory category or proof of a clinical effect.
A–Z reference
Plain-language definitions for mycology, supplements, research, and psychedelic harm reduction.

A marketing and herbal-medicine term for substances claimed to help the body respond to stress. It is not a precise regulatory category or proof of a clinical effect.
A broad class of nitrogen-containing compounds. Psilocybin and psilocin are indole alkaloids.
A carbohydrate category that includes starch. High alpha-glucan levels can indicate substantial grain or other starch in a mushroom product.
A pale phenotype with reduced pigmentation. In cultivated mushroom names, the term is sometimes used loosely and may overlap with leucistic.
A minor psilocybin-related compound found in some mushroom species. Its contribution to human effects is not well established.
A group of structural polysaccharides found in fungal cell walls. Measured beta-glucans are a useful, though incomplete, supplement quality marker.
The amount and rate at which a substance becomes available to the body after use.
A tough structural material in fungal cell walls, also found in arthropod shells.
A hard bracket-like fungal growth, often found on wood. Chaga’s harvested sterile conk is not a conventional cap.
A compound associated with Cordyceps militaris and studied in laboratory research. Its presence does not by itself prove a health benefit.
A selected cultivated line. Mushroom trade names are often called strains or cultivars, even when their genetics are not formally registered.
The amount taken. For mushrooms, dose alone cannot predict intensity because species, batch, form, individual biology, and context all matter.
An extract made using both water and alcohol, intended to capture different compound groups.
A cultural term for a psychoactive substance used in spiritual or religious contexts. Legal definitions vary.
A label such as 8:1 that claims a relationship between starting material and finished extract. It does not state the final composition by itself.
The spore-producing structure people usually recognize as a mushroom.
A non-regulatory wellness category for mushrooms used beyond ordinary nutrition. The label is not evidence that a product has a proven benefit.
A microscopic fungal filament. Networks of hyphae form mycelium.
A phenotype with reduced pigment, but not necessarily the complete loss associated with true albinism.
A small amount intended to produce little or no obvious perceptual change. The term has no single scientific definition and sub-perceptual intent is not guaranteed.
The branching network of fungal hyphae that grows through a substrate.
The scientific study of fungi.
A broad marketing term for substances promoted for cognition. It does not establish safety or effectiveness.
The amount of active compound relative to material. Mushroom potency can vary among species, batches, and individual specimens.
The psychoactive compound that primarily acts at serotonin receptors after psilocybin is converted in the body.
A naturally occurring psychedelic compound and a Schedule I controlled substance under US federal law.
‘Set’ means a person’s mindset and condition; ‘setting’ means the physical and social environment. Both can shape a psychedelic experience.
A biological classification. Species identity is more fundamental than an informal trade strain name.
A useful marketplace term for a cultivated line, but often not a formally registered or genetically verified category.
Testing performed by a laboratory separate from the seller. The methods, date, sample identity, and accessible report still matter.
A sober, trusted person who stays present to support safety without directing or escalating an experience.
A broad compound class found in reishi and many other organisms. Measured content varies by species and extraction.
Dried material ground into powder rather than concentrated through extraction.